Join Pennsylvania Bio on August 19, 2010, for our evening cocktail reception and program, Creative and Changing Deal Structures. Over the past 18 months, bioscience companies have experienced numerous challenges in their quests to succeed, including diminished investments, partnering, or acquisition options. This situation has forced companies to become increasingly creative in structuring transactions that provide financing, growth, and exit opportunities.
Our panelists will discuss how companies have recently been using new approaches to:
Reposition, extend, and out-license compounds and products
Gain access to new technologies, create operational synergies, and/or reduce R&D expenses
Obtain alternative sources of financing
Achieve acceptable exits for management and investors
Panelists:
Sponsored by:
Back to the e-newsletter
